Vendor, Branford, CT
Tangen Biosciences, Inc.
UEI K3D1V93LH4F8, CAGE 6ZYQ1
2 awards and -$296,500 obligated between May 30, 2024 and September 30, 2025, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | -$296,500 |
Industries
NAICS on the awards, by dollars.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSO100201700028CDefinitive Contract, September 30, 2025, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | The Purpose of This Modification Is to Deobligate Funding in the Amount of $500.00 in Cancelling Funds from Clin 0002. End of Modification.NAICS 541711, PSC AN41 | -$500 |
| 75A50120C00085Definitive Contract, May 30, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Tangen Sars-Cov-2 Assay - Nce to Allow Time for the Eua to Move Through FDA Approval.NAICS 541715, PSC AN13 | -$296,000 |
- Places of performance
- Connecticut
- Product and service codes
- AN41 Health R&D Services; Health Care - Other; Basic ResearchAN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 2 across 2 awards